Our current trustee and former BHF Professor, Dame Anna Dominiczak, has been appointed to a new role at the MRC to forge innovation and collaboration between academics and commercial partners.
Professor Anna Dominiczak is one of the world’s leading heart and circulatory disease scientists and clinical academics. Based at the University of Glasgow, she is a Regius Professor of Medicine, Vice Principal and Head of College of Medical, Veterinary and Life Sciences - the largest of four Colleges at the university. She is also an honorary consultant physician and non-executive member of the NHS Greater Glasgow and Clyde Health Board.
Expertise in hypertension, genetics and body systems
Appointed as one of our Trustee’s in 2014, Professor Dominiczak previously held a British Heart Foundation Chair of Cardiovascular Medicine at the University of Glasgow between 1998 and 2010, and directed the Cardiovascular Research Centre between 2000 and 2010.
Professor Dominiczak is an active member on countless research committees and boards. Her world leading research focuses on hypertension, genetics and body systems. In 2016, her services to medicine were recognised by the Queen who awarded her a DBE.
World leading research
On her new role Professor Dominiczak said: “I am delighted to be chosen for this senior role within the MRC. The MRC supports some of the world’s most important research and is dedicated to improving health through innovation. I look forward to playing a part in that and sharing my expertise, and that of the University of Glasgow, as we work together to drive health innovation.”
Simon Gillespie, our Chief Executive commented on the news:
“We’re thrilled that our Trustee Professor Anna Dominiczak has been appointed the MRC Health Innovation Champion. She’s made exceptional contributions to the advancement in our understanding of heart and circulatory disease – much of this work funded by the BHF – and her expertise will be invaluable in this role.
“Collaborating across sectors and investing in innovation have the potential to accelerate breakthroughs in medical research, and we look forward to what is to come.”
Read about our Trustees